Company / Inventory
Bioventus Inc. Inventory History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$82.2M
FY2025
5-year range
$61.7M / $92.5M
FY2021-FY2025
Trend
-11.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $91M to $82M over the past 2 years.
Based on SEC 10-K filings.
$82M in FY2025 with a 3-year CAGR of -1.0%.
Declined from $91M to $82M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, inventory decreased 11.1% year-over-year.
- Peak inventory was recorded in FY2024.
- Lowest inventory in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.2M | -11.1% |
| FY2024 | $92.5M | +1.3% |
| FY2023 | $91.3M | +7.7% |
| FY2022 | $84.8M | +37.4% |
| FY2021 | $61.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026